Skip to main content

and
  1. Article

    Open Access

    Effect of empagliflozin on ventricular arrhythmias in patients with type 2 diabetes treated with an implantable cardioverter-defibrillator: the EMPA-ICD trial

    Sodium-glucose cotransporter 2 (SGLT2) inhibitors reduce the risk of hospitalization for heart failure and cardiovascular death with type 2 diabetes; however, their effect on arrhythmias is unclear. The purpos...

    Shinya Fujiki, Kenichi Iijima, Yoshihisa Nakagawa in Cardiovascular Diabetology (2024)